The Sonic Healthcare (ASX:SHL) share price is rising this Wednesday

The medical diagnostics company is having a strong day despite a so-so market.

| More on:
A group of three scientists talking excitedly while working in a lab on a diabetes test developed by Proteomics International Laboratories which is an ASX share tipped to explode by Alto Capital

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Sonic Healthcare Limited (ASX: SHL) share price is having a strong session this hump day.

At the time of writing, shares in the medical diagnostics company are trading for $40.73, up 3.77%. For context, the S&P/ASX 200 Index (ASX: XJO) is practically even on yesterday's close.

The company hasn't released any price sensitive news recently. So, what's going on?

Let's take a closer look.

Could learning to 'live with COVID' be the reason?

Since the first case of the delta variant of COVID in late June, thousands upon thousands of cases have been detected across the Australian mainland – shutting down New South Wales, Victoria, and the ACT for extended time periods.

But those days are over.

NSW and Victoria are out of lockdown and the ACT is practically there. Quarantine for international travel will also soon be a thing of the past. Australia has become a highly vaccinated country and is learning to live alongside the insidious virus.

Part of living with the virus means testing — and Sonic is the largest private testing provider in the country. It's raked in millions of dollars from government as people get tested by the tens of thousands. The Sonic share price had a massive rise during this latest outbreak. It's jumped 10.9% since the original case was detected in the Sydney limo driver.

Testing, contact tracing, and isolating positive COVID patients will still be a part of the Australian response to the disease.

As well, the Commonwealth government has today revealed the end of Australia's closed border policy. Come 1 November, Australians will no longer need a reason to leave the country. The date coincides with the day NSW and Victoria end all quarantine requirements for vaccinated travellers.

However, to fly overseas, passengers will need to conduct a PCR (polymerase chain reaction) test within 72 hours before departure. These tests can only be done in a clinical setting, meaning Sonic's revenue stream is not drying up anytime soon.

Investors may be jumping on this news, thus, potentially leading to a rising Sonic share price.

Sonic share price snapshot

Over the past 12 months, the Sonic share price has risen 13.5%. Since the start of 2021, shares in the medical company have risen 26.5%. Its 52-week high is $43.99 and its 52-week low is $30.21.

Sonic Healthcare has a market capitalisation of approximately $19.5 billion.

Motley Fool contributor Marc Sidarous has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Researchers and doctors with futuristic 3d hologram overlay for body anatomy or dna in hospital clinic.
Healthcare Shares

Why investors are watching this ASX healthcare stock

A fresh clinical update has been released.

Read more »

A Sonic Healthcare medical researcher wearing a white coat sits at her desk in a laboratory conducting a COVID-19 test
Healthcare Shares

This biotech is up more than 20% on new deal news

Revenue will flow under this global deal just announced.

Read more »

A male doctor and a woman in scrubs in the foreground smile.
Healthcare Shares

The next 3 years could be huge for this ASX healthcare stock. Here's why

Today's update has put this ASX healthcare stock back in the spotlight as investors reassess its long-term growth potential.

Read more »

A doctor sits with a patient and uses a pen to point to certain parts of her mammogram scan
Healthcare Shares

Top broker says this ASX small-cap healthcare stock could be set to double

This company is making significant clinical and commercial progress .

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

3 quality ASX healthcare shares worth buying now

Brokers think the tide is turning for these battling medical heavyweights.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Early success in battling Crohn's Disease has sent this ASX biotech's shares soaring

The early-stage results have been described as outstanding.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

Why are 4DMedical shares in a trading halt today?

The company is looking to raise fresh capital.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX biotech's shares are up strongly on good news out of the US

The addressable market for this newly approved software is huge.

Read more »